Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-12-31 Option Award | 2026-01-05 5:21 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 36,250 | $0 | 105,180 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:21 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 668,640 | $0 | 3,481,238 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:21 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 255,331 | $0 | 1,448,664 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:20 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 231,328 | $0 | 1,064,495 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:20 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 33,500 | $0 | 2,023,220 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-05 5:20 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 34,900 | $0 | 168,009 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-02 8:02 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 36,250 | $0 | 113,441 (Direct) | View |
| 2025-12-31 Option Award | 2026-01-02 8:00 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 215,216 | $0 | 649,256 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:08 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 36,975 | $0 | 133,109 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:08 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 38,371 | $0 | 77,191 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:08 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 38,370 | $0 | 68,930 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 36,510 | $0 | 134,531 (Direct) | View |
| 2025-06-05 Option Award | 2025-06-09 4:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 34,650 | $0 | 1,989,720 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-11 4:31 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 192,667 | $0 | 1,193,333 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-11 4:31 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 126,834 | $0 | 833,167 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-11 4:31 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 427,000 | $0 | 2,812,598 (Direct) | View |
| 2025-02-11 Option Award | 2025-02-11 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 76,000 | $0 | 434,040 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 433,500 | $0 | 2,385,598 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 188,000 | $0 | 358,040 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 207,000 | $0 | 1,000,666 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-06 4:10 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 194,500 | $0 | 706,333 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 30,000 | $0 | 170,040 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 45,000 | $0 | 1,952,098 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 30,000 | $0 | 793,666 (Direct) | View |
| 2024-11-07 Option Award | 2024-11-08 4:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 30,000 | $0 | 511,833 (Direct) | View |
| 2024-06-21 Option Award | 2024-06-21 4:15 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Gabay Avraham Chief Financial Officer | 140,040 | $0 | 0 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-10 5:15 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 760 | $0 | 30,560 (Direct) | View |
| 2024-04-17 Option Award | 2024-04-18 8:07 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Reznick Yehuda Director | 29,800 | $0 | 29,800 (Direct) | View |
| 2024-01-30 Option Award | 2024-01-30 5:30 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 3,750 | $0 | 38,820 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:43 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Kidron Miriam Chief Scientific Officer | 295,500 | $0 | 763,666 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:41 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | KIDRON NADAV President and CEO | 329,000 | $0 | 1,907,098 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:40 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Hexter Joshua COO & CBO | 180,500 | $0 | 481,833 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:39 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Silberman David Chief Financial Officer | 136,500 | $0 | 366,500 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:37 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Sank Leonard Director | 39,325 | $0 | 98,021 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:36 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Rozov Yadin Director | 38,820 | $0 | 155,320 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:34 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Mayer Arie Director | 39,325 | $0 | 96,134 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:33 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Aghion Daniel Director | 35,070 | $0 | 35,070 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:32 pm | N/A N/A | ORAMED PHARMACEUTICALS INC. | ORMP | Shapiro Benjamin Director | 35,070 | $0 | 1,955,070 (Direct) | View |